date
Note that the current default version of R is 3.6.1.
Loading required package: network
network: Classes for Relational Data
Version 1.15 created on 2019-04-01.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
                    Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Martina Morris, University of Washington
                    Skye Bender-deMoll, University of Washington
 For citation information, type citation("network").
 Type help("network-package") to get started.


networkDynamic: version 0.10.0, created on 2019-04-04
Copyright (c) 2019, Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Skye Bender-deMoll, University of Washington
                    with contributions from
                    Zack Almquist, University of California -- Irvine
                    David R. Hunter, Penn State University
                    Li Wang
                    Kirk Li, University of Washington
                    Steven M. Goodreau, University of Washington
                    Jeffrey Horner
                    Martina Morris, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("networkDynamic").

Loading required package: statnet.common

Attaching package: ‘statnet.common’

The following object is masked from ‘package:base’:

    order

sna: Tools for Social Network Analysis
Version 2.4 created on 2016-07-23.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
 For citation information, type citation("sna").
 Type help(package="sna") to get started.


ergm: version 3.10.4, created on 2019-06-10
Copyright (c) 2019, Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Carter T. Butts, University of California -- Irvine
                    Steven M. Goodreau, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Martina Morris, University of Washington
                    with contributions from
                    Li Wang
                    Kirk Li, University of Washington
                    Skye Bender-deMoll, University of Washington
                    Chad Klumb
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("ergm").

NOTE: Versions before 3.6.1 had a bug in the implementation of the bd()
constriant which distorted the sampled distribution somewhat. In
addition, Sampson's Monks datasets had mislabeled vertices. See the
NEWS and the documentation for more details.

NOTE: Some common term arguments pertaining to vertex attribute and
level selection have changed in 3.10.0. See terms help for more
details. Use ‘options(ergm.term=list(version="3.9.4"))’ to use old
behavior.


tergm: version 3.6.1, created on 2019-06-12
Copyright (c) 2019, Pavel N. Krivitsky, University of Wollongong
                    Mark S. Handcock, University of California -- Los Angeles
                    with contributions from
                    David R. Hunter, Penn State University
                    Steven M. Goodreau, University of Washington
                    Martina Morris, University of Washington
                    Nicole Bohme Carnegie, New York University
                    Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Skye Bender-deMoll
                    Li Wang
                    Kirk Li, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("tergm").

Starting maximum pseudolikelihood estimation (MPLE):
Evaluating the predictor and response matrix.
Maximizing the pseudolikelihood.
Finished MPLE.
Starting Monte Carlo maximum likelihood estimation (MCMLE):
Iteration 1 of at most 500:
Optimizing with step length 0.493895547840058.
The log-likelihood improved by 7.591.
Iteration 2 of at most 500:
Optimizing with step length 0.475482669291554.
The log-likelihood improved by 3.631.
Iteration 3 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 3.399.
Step length converged once. Increasing MCMC sample size.
Iteration 4 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.07718.
Step length converged twice. Stopping.
Finished MCMLE.
This model was fit using MCMC.  To examine model diagnostics and check
for degeneracy, use the mcmc.diagnostics() function.
 degree0  degree1  degree2  degree3  degree4  degree5  degree6  degree7 
       2       20     1218     1063      786      345      369      332 
 degree8  degree9 degree10 degree11 degree12 degree13 degree14 degree15 
     281      248      152       87       52       28       13        2 
degree16 degree19 
       1        1 
1 
disease_progression 
H-positive risk:  912 878 136 834 438 126 873 420 143 65 116 59 
H-negative risk:  878 912 873 834 420 438 126 136 116 143 59 65 
New BC onsets:  2
BC status:  4998 2 
BC subtype:  4998 1 1 

clinical_engagement 
diagnosis 
demography 
60 new agents 
2 
disease_progression 
H-positive risk:  917 884 136 832 434 126 868 421 143 65 117 57 
H-negative risk:  884 917 868 832 421 434 126 136 117 143 57 65 
New BC onsets:  3
BC status:  4997 3 
BC subtype:  4997 2 1 

clinical_engagement 
diagnosis 
demography 
51 new agents 
3 
disease_progression 
H-positive risk:  921 889 135 830 436 127 858 417 144 66 119 58 
H-negative risk:  889 921 858 830 417 436 127 135 119 144 58 66 
New BC onsets:  4
BC status:  4996 4 
BC subtype:  4996 3 1 

clinical_engagement 
diagnosis 
demography 
57 new agents 
4 
disease_progression 
H-positive risk:  925 893 136 830 429 126 860 416 143 66 120 56 
H-negative risk:  893 925 860 830 416 429 126 136 120 143 56 66 
New BC onsets:  7
BC status:  4993 7 
BC subtype:  4993 4 3 

clinical_engagement 
diagnosis 
demography 
54 new agents 
5 
disease_progression 
H-positive risk:  931 895 138 832 421 126 862 411 143 64 121 56 
H-negative risk:  895 931 862 832 411 421 126 138 121 143 56 64 
New BC onsets:  11
BC status:  4989 11 
BC subtype:  4989 6 5 

clinical_engagement 
diagnosis 
demography 
58 new agents 
6 
disease_progression 
H-positive risk:  936 903 135 839 419 125 855 409 140 63 121 55 
H-negative risk:  903 936 855 839 409 419 125 135 121 140 55 63 
New BC onsets:  11
BC status:  4989 11 
BC subtype:  4989 6 5 

clinical_engagement 
diagnosis 
demography 
68 new agents 
7 
disease_progression 
H-positive risk:  943 907 134 842 414 126 843 412 138 63 124 54 
H-negative risk:  907 943 843 842 412 414 126 134 124 138 54 63 
New BC onsets:  12
BC status:  4988 12 
BC subtype:  4988 7 5 

clinical_engagement 
diagnosis 
demography 
64 new agents 
8 
disease_progression 
H-positive risk:  953 908 132 831 417 125 845 409 139 62 125 54 
H-negative risk:  908 953 845 831 409 417 125 132 125 139 54 62 
New BC onsets:  17
BC status:  4983 17 
BC subtype:  4983 12 5 

clinical_engagement 
diagnosis 
demography 
58 new agents 
9 
disease_progression 
H-positive risk:  958 908 134 830 415 126 848 406 137 61 123 54 
H-negative risk:  908 958 848 830 406 415 126 134 123 137 54 61 
New BC onsets:  18
BC status:  4982 18 
BC subtype:  4982 13 5 

clinical_engagement 
diagnosis 
demography 
61 new agents 
10 
disease_progression 
H-positive risk:  962 916 135 828 407 129 844 407 137 61 122 52 
H-negative risk:  916 962 844 828 407 407 129 135 122 137 52 61 
New BC onsets:  24
BC status:  4976 24 
BC subtype:  4976 18 6 

clinical_engagement 
diagnosis 
demography 
75 new agents 
11 
disease_progression 
H-positive risk:  968 918 133 823 403 129 855 398 137 62 123 51 
H-negative risk:  918 968 855 823 398 403 129 133 123 137 51 62 
New BC onsets:  25
BC status:  4975 25 
BC subtype:  4975 18 7 

clinical_engagement 
diagnosis 
demography 
46 new agents 
12 
disease_progression 
H-positive risk:  979 917 134 819 401 128 854 395 136 63 122 52 
H-negative risk:  917 979 854 819 395 401 128 134 122 136 52 63 
New BC onsets:  28
BC status:  4972 28 
BC subtype:  4972 20 8 

clinical_engagement 
diagnosis 
demography 
66 new agents 
13 
disease_progression 
H-positive risk:  909 852 124 884 397 114 924 397 152 64 133 50 
H-negative risk:  852 909 924 884 397 397 114 124 133 152 50 64 
New BC onsets:  32
BC status:  4968 32 
BC subtype:  4968 23 9 

clinical_engagement 
diagnosis 
demography 
220 new agents 
14 
disease_progression 
H-positive risk:  942 889 126 830 420 119 882 406 141 66 128 51 
H-negative risk:  889 942 882 830 406 420 119 126 128 141 51 66 
New BC onsets:  37
BC status:  4963 37 
BC subtype:  4963 25 12 

clinical_engagement 
diagnosis 
demography 
58 new agents 
15 
disease_progression 
H-positive risk:  950 893 127 825 413 119 884 406 139 62 130 52 
H-negative risk:  893 950 884 825 406 413 119 127 130 139 52 62 
New BC onsets:  37
BC status:  4963 37 
BC subtype:  4963 26 11 

clinical_engagement 
diagnosis 
demography 
62 new agents 
16 
disease_progression 
H-positive risk:  948 892 128 829 412 121 876 408 139 63 130 54 
H-negative risk:  892 948 876 829 408 412 121 128 130 139 54 63 
New BC onsets:  40
BC status:  4960 40 
BC subtype:  4960 29 11 

clinical_engagement 
diagnosis 
demography 
78 new agents 
17 
disease_progression 
H-positive risk:  956 897 130 829 404 122 875 407 137 62 128 53 
H-negative risk:  897 956 875 829 407 404 122 130 128 137 53 62 
New BC onsets:  45
BC status:  4955 45 
BC subtype:  4955 33 12 

clinical_engagement 
diagnosis 
demography 
65 new agents 
18 
disease_progression 
H-positive risk:  957 897 131 834 401 123 877 402 139 61 127 51 
H-negative risk:  897 957 877 834 402 401 123 131 127 139 51 61 
New BC onsets:  48
BC status:  4952 48 
BC subtype:  4952 36 12 

clinical_engagement 
diagnosis 
demography 
63 new agents 
19 
disease_progression 
H-positive risk:  959 910 131 829 393 124 877 400 141 60 125 51 
H-negative risk:  910 959 877 829 400 393 124 131 125 141 51 60 
New BC onsets:  44
BC status:  4956 44 
BC subtype:  4956 33 11 

clinical_engagement 
diagnosis 
demography 
61 new agents 
20 
disease_progression 
H-positive risk:  962 919 132 830 387 124 878 394 139 58 125 52 
H-negative risk:  919 962 878 830 394 387 124 132 125 139 52 58 
New BC onsets:  42
BC status:  4958 42 
BC subtype:  4958 32 10 

clinical_engagement 
diagnosis 
demography 
55 new agents 
21 
disease_progression 
H-positive risk:  963 916 132 836 388 122 873 394 139 58 128 51 
H-negative risk:  916 963 873 836 394 388 122 132 128 139 51 58 
New BC onsets:  44
BC status:  4956 44 
BC subtype:  4956 32 12 

clinical_engagement 
diagnosis 
demography 
44 new agents 
22 
disease_progression 
H-positive risk:  964 921 131 836 388 122 876 391 137 57 126 51 
H-negative risk:  921 964 876 836 391 388 122 131 126 137 51 57 
New BC onsets:  45
BC status:  4955 45 
BC subtype:  4955 34 11 

clinical_engagement 
diagnosis 
demography 
66 new agents 
23 
disease_progression 
H-positive risk:  975 927 131 832 382 124 878 386 136 54 126 49 
H-negative risk:  927 975 878 832 386 382 124 131 126 136 49 54 
New BC onsets:  48
BC status:  4952 48 
BC subtype:  4952 36 12 

clinical_engagement 
diagnosis 
demography 
68 new agents 
24 
disease_progression 
H-positive risk:  980 926 131 836 376 126 876 382 136 55 127 49 
H-negative risk:  926 980 876 836 382 376 126 131 127 136 49 55 
New BC onsets:  51
BC status:  4949 51 
BC subtype:  4949 39 12 

clinical_engagement 
diagnosis 
demography 
58 new agents 
25 
disease_progression 
H-positive risk:  926 855 122 907 378 117 929 378 144 55 139 50 
H-negative risk:  855 926 929 907 378 378 117 122 139 144 50 55 
New BC onsets:  51
BC status:  4949 51 
BC subtype:  4949 38 13 

clinical_engagement 
diagnosis 
demography 
164 new agents 
26 
disease_progression 
H-positive risk:  952 873 123 884 376 119 893 394 138 63 134 51 
H-negative risk:  873 952 893 884 394 376 119 123 134 138 51 63 
New BC onsets:  53
BC status:  4947 53 
BC subtype:  4947 37 16 

clinical_engagement 
diagnosis 
demography 
61 new agents 
27 
disease_progression 
H-positive risk:  958 869 125 886 374 118 900 387 134 67 132 50 
H-negative risk:  869 958 900 886 387 374 118 125 132 134 50 67 
New BC onsets:  53
BC status:  4947 53 
BC subtype:  4947 38 15 

clinical_engagement 
diagnosis 
demography 
54 new agents 
28 
disease_progression 
H-positive risk:  960 867 126 884 369 117 908 390 133 67 130 49 
H-negative risk:  867 960 908 884 390 369 117 126 130 133 49 67 
New BC onsets:  56
BC status:  4944 56 
BC subtype:  4944 40 16 

clinical_engagement 
diagnosis 
demography 
62 new agents 
29 
disease_progression 
H-positive risk:  954 878 127 885 369 118 906 388 132 64 131 48 
H-negative risk:  878 954 906 885 388 369 118 127 131 132 48 64 
New BC onsets:  57
BC status:  4943 57 
BC subtype:  4943 41 16 

clinical_engagement 
diagnosis 
demography 
56 new agents 
30 
disease_progression 
H-positive risk:  957 878 129 880 367 118 898 397 132 64 131 49 
H-negative risk:  878 957 898 880 397 367 118 129 131 132 49 64 
New BC onsets:  60
BC status:  4940 60 
BC subtype:  4940 41 19 

clinical_engagement 
diagnosis 
demography 
51 new agents 
31 
disease_progression 
H-positive risk:  958 879 128 884 365 117 889 402 132 65 131 50 
H-negative risk:  879 958 889 884 402 365 117 128 131 132 50 65 
New BC onsets:  63
BC status:  4937 63 
BC subtype:  4937 44 19 

clinical_engagement 
diagnosis 
demography 
52 new agents 
32 
disease_progression 
H-positive risk:  968 885 128 888 358 120 881 398 132 62 131 49 
H-negative risk:  885 968 881 888 398 358 120 128 131 132 49 62 
New BC onsets:  64
BC status:  4936 64 
BC subtype:  4936 46 18 

clinical_engagement 
diagnosis 
demography 
54 new agents 
33 
disease_progression 
H-positive risk:  974 878 129 897 347 118 883 398 132 63 133 48 
H-negative risk:  878 974 883 897 398 347 118 129 133 132 48 63 
New BC onsets:  67
BC status:  4933 67 
BC subtype:  4933 49 18 

clinical_engagement 
diagnosis 
demography 
64 new agents 
34 
disease_progression 
H-positive risk:  972 885 131 892 343 120 879 404 132 62 133 47 
H-negative risk:  885 972 879 892 404 343 120 131 133 132 47 62 
New BC onsets:  68
BC status:  4932 68 
BC subtype:  4932 50 18 

clinical_engagement 
diagnosis 
demography 
43 new agents 
35 
disease_progression 
H-positive risk:  976 881 129 890 344 119 884 400 135 63 132 47 
H-negative risk:  881 976 884 890 400 344 119 129 132 135 47 63 
New BC onsets:  67
BC status:  4933 67 
BC subtype:  4933 50 17 

clinical_engagement 
diagnosis 
demography 
73 new agents 
36 
disease_progression 
H-positive risk:  976 889 131 891 340 119 878 399 131 63 135 48 
H-negative risk:  889 976 878 891 399 340 119 131 135 131 48 63 
New BC onsets:  68
BC status:  4932 68 
BC subtype:  4932 51 17 

clinical_engagement 
diagnosis 
demography 
69 new agents 
37 
disease_progression 
H-positive risk:  896 809 121 971 337 109 956 397 142 63 147 52 
H-negative risk:  809 896 956 971 397 337 109 121 147 142 52 63 
New BC onsets:  70
BC status:  4930 70 
BC subtype:  4930 52 18 

clinical_engagement 
diagnosis 
demography 
155 new agents 
38 
disease_progression 
H-positive risk:  899 825 122 948 355 112 922 419 134 67 148 49 
H-negative risk:  825 899 922 948 419 355 112 122 148 134 49 67 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 53 18 

clinical_engagement 
diagnosis 
demography 
74 new agents 
39 
disease_progression 
H-positive risk:  907 829 120 930 357 114 921 424 134 68 149 47 
H-negative risk:  829 907 921 930 424 357 114 120 149 134 47 68 
New BC onsets:  69
BC status:  4931 69 
BC subtype:  4931 51 18 

clinical_engagement 
diagnosis 
demography 
65 new agents 
40 
disease_progression 
H-positive risk:  908 835 121 925 358 114 927 418 132 66 147 49 
H-negative risk:  835 908 927 925 418 358 114 121 147 132 49 66 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 53 18 

clinical_engagement 
diagnosis 
demography 
74 new agents 
41 
disease_progression 
H-positive risk:  907 835 122 933 357 114 922 413 135 65 148 49 
H-negative risk:  835 907 922 933 413 357 114 122 148 135 49 65 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 54 17 

clinical_engagement 
diagnosis 
demography 
70 new agents 
42 
disease_progression 
H-positive risk:  914 845 123 937 348 112 917 407 132 67 149 49 
H-negative risk:  845 914 917 937 407 348 112 123 149 132 49 67 
New BC onsets:  73
BC status:  4927 73 
BC subtype:  4927 54 19 

clinical_engagement 
diagnosis 
demography 
67 new agents 
43 
disease_progression 
H-positive risk:  908 850 124 940 347 111 924 401 130 68 149 48 
H-negative risk:  850 908 924 940 401 347 111 124 149 130 48 68 
New BC onsets:  73
BC status:  4927 73 
BC subtype:  4927 54 19 

clinical_engagement 
diagnosis 
demography 
74 new agents 
44 
disease_progression 
H-positive risk:  905 854 127 940 340 114 931 392 131 66 153 47 
H-negative risk:  854 905 931 940 392 340 114 127 153 131 47 66 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 54 20 

clinical_engagement 
diagnosis 
demography 
67 new agents 
45 
disease_progression 
H-positive risk:  908 853 128 939 331 115 943 390 129 65 154 45 
H-negative risk:  853 908 943 939 390 331 115 128 154 129 45 65 
New BC onsets:  73
BC status:  4927 73 
BC subtype:  4927 55 18 

clinical_engagement 
diagnosis 
demography 
66 new agents 
46 
disease_progression 
H-positive risk:  914 852 128 937 339 112 939 384 129 64 154 48 
H-negative risk:  852 914 939 937 384 339 112 128 154 129 48 64 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 54 18 

clinical_engagement 
diagnosis 
demography 
73 new agents 
47 
disease_progression 
H-positive risk:  912 854 129 936 337 115 936 385 129 66 153 48 
H-negative risk:  854 912 936 936 385 337 115 129 153 129 48 66 
New BC onsets:  75
BC status:  4925 75 
BC subtype:  4925 57 18 

clinical_engagement 
diagnosis 
demography 
70 new agents 
48 
disease_progression 
H-positive risk:  911 861 129 933 332 114 940 389 128 63 153 47 
H-negative risk:  861 911 940 933 389 332 114 129 153 128 47 63 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 61 18 

clinical_engagement 
diagnosis 
demography 
68 new agents 
49 
disease_progression 
H-positive risk:  844 810 114 986 331 109 1003 398 132 60 168 45 
H-negative risk:  810 844 1003 986 398 331 109 114 168 132 45 60 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 61 18 

clinical_engagement 
diagnosis 
demography 
127 new agents 
50 
disease_progression 
H-positive risk:  846 813 118 975 347 111 989 394 126 66 161 54 
H-negative risk:  813 846 989 975 394 347 111 118 161 126 54 66 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 60 18 

clinical_engagement 
diagnosis 
demography 
75 new agents 
51 
disease_progression 
H-positive risk:  846 825 118 970 343 110 987 395 128 64 160 54 
H-negative risk:  825 846 987 970 395 343 110 118 160 128 54 64 
New BC onsets:  75
BC status:  4925 75 
BC subtype:  4925 59 16 

clinical_engagement 
diagnosis 
demography 
67 new agents 
52 
disease_progression 
H-positive risk:  848 828 119 971 347 109 990 383 127 64 161 53 
H-negative risk:  828 848 990 971 383 347 109 119 161 127 53 64 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 59 15 

clinical_engagement 
diagnosis 
demography 
57 new agents 
53 
disease_progression 
H-positive risk:  856 832 117 969 347 109 982 379 129 62 163 55 
H-negative risk:  832 856 982 969 379 347 109 117 163 129 55 62 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 63 15 

clinical_engagement 
diagnosis 
demography 
65 new agents 
54 
disease_progression 
H-positive risk:  858 840 117 968 346 109 985 372 126 62 161 56 
H-negative risk:  840 858 985 968 372 346 109 117 161 126 56 62 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 63 15 

clinical_engagement 
diagnosis 
demography 
59 new agents 
55 
disease_progression 
H-positive risk:  865 836 117 973 345 109 985 367 125 60 160 58 
H-negative risk:  836 865 985 973 367 345 109 117 160 125 58 60 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 65 15 

clinical_engagement 
diagnosis 
demography 
66 new agents 
56 
disease_progression 
H-positive risk:  867 840 116 970 347 110 992 356 123 61 161 57 
H-negative risk:  840 867 992 970 356 347 110 116 161 123 57 61 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 67 15 

clinical_engagement 
diagnosis 
demography 
70 new agents 
57 
disease_progression 
H-positive risk:  875 841 113 967 346 110 988 357 124 60 160 59 
H-negative risk:  841 875 988 967 357 346 110 113 160 124 59 60 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 68 16 

clinical_engagement 
diagnosis 
demography 
59 new agents 
58 
disease_progression 
H-positive risk:  886 844 113 958 343 109 984 357 127 59 161 59 
H-negative risk:  844 886 984 958 357 343 109 113 161 127 59 59 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 69 15 

clinical_engagement 
diagnosis 
demography 
60 new agents 
59 
disease_progression 
H-positive risk:  889 848 112 958 338 110 982 359 129 58 158 59 
H-negative risk:  848 889 982 958 359 338 110 112 158 129 59 58 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 70 15 

clinical_engagement 
diagnosis 
demography 
55 new agents 
60 
disease_progression 
H-positive risk:  886 849 112 955 338 113 977 363 128 61 157 61 
H-negative risk:  849 886 977 955 363 338 113 112 157 128 61 61 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 69 17 

clinical_engagement 
diagnosis 
demography 
70 new agents 
61 
disease_progression 
H-positive risk:  843 799 99 1004 334 105 1026 361 138 60 168 63 
H-negative risk:  799 843 1026 1004 361 334 105 99 168 138 63 60 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 70 17 

clinical_engagement 
diagnosis 
demography 
122 new agents 
62 
disease_progression 
H-positive risk:  853 798 100 987 349 105 1012 372 130 66 159 69 
H-negative risk:  798 853 1012 987 372 349 105 100 159 130 69 66 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 69 18 

clinical_engagement 
diagnosis 
demography 
99 new agents 
63 
disease_progression 
H-positive risk:  856 807 101 984 353 105 1004 370 131 61 160 68 
H-negative risk:  807 856 1004 984 370 353 105 101 160 131 68 61 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 70 18 

clinical_engagement 
diagnosis 
demography 
84 new agents 
64 
disease_progression 
H-positive risk:  867 809 100 992 354 106 983 369 133 63 160 64 
H-negative risk:  809 867 983 992 369 354 106 100 160 133 64 63 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 71 17 

clinical_engagement 
diagnosis 
demography 
70 new agents 
65 
disease_progression 
H-positive risk:  873 810 101 984 353 107 981 374 133 60 161 63 
H-negative risk:  810 873 981 984 374 353 107 101 161 133 63 60 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 71 17 

clinical_engagement 
diagnosis 
demography 
57 new agents 
66 
disease_progression 
H-positive risk:  874 807 103 988 353 110 981 372 132 56 162 62 
H-negative risk:  807 874 981 988 372 353 110 103 162 132 62 56 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 69 17 

clinical_engagement 
diagnosis 
demography 
52 new agents 
67 
disease_progression 
H-positive risk:  876 803 105 992 351 111 989 364 132 54 162 61 
H-negative risk:  803 876 989 992 364 351 111 105 162 132 61 54 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 73 16 

clinical_engagement 
diagnosis 
demography 
67 new agents 
68 
disease_progression 
H-positive risk:  873 809 105 985 350 111 991 367 133 52 163 61 
H-negative risk:  809 873 991 985 367 350 111 105 163 133 61 52 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 72 15 

clinical_engagement 
diagnosis 
demography 
64 new agents 
69 
disease_progression 
H-positive risk:  881 809 107 982 351 111 991 364 132 51 161 60 
H-negative risk:  809 881 991 982 364 351 111 107 161 132 60 51 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 72 15 

clinical_engagement 
diagnosis 
demography 
86 new agents 
70 
disease_progression 
H-positive risk:  894 812 108 977 347 112 991 355 131 54 159 60 
H-negative risk:  812 894 991 977 355 347 112 108 159 131 60 54 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 71 17 

clinical_engagement 
diagnosis 
demography 
66 new agents 
71 
disease_progression 
H-positive risk:  899 819 108 978 343 111 993 347 132 54 155 61 
H-negative risk:  819 899 993 978 347 343 111 108 155 132 61 54 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 73 17 

clinical_engagement 
diagnosis 
demography 
67 new agents 
72 
disease_progression 
H-positive risk:  902 822 111 973 342 109 994 343 132 55 158 59 
H-negative risk:  822 902 994 973 343 342 109 111 158 132 59 55 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 72 17 

clinical_engagement 
diagnosis 
demography 
53 new agents 
73 
disease_progression 
H-positive risk:  846 774 110 1032 342 103 1045 338 136 54 160 60 
H-negative risk:  774 846 1045 1032 338 342 103 110 160 136 60 54 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 72 17 

clinical_engagement 
diagnosis 
demography 
129 new agents 
74 
disease_progression 
H-positive risk:  859 772 116 1019 353 103 1026 345 138 54 154 61 
H-negative risk:  772 859 1026 1019 345 353 103 116 154 138 61 54 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 74 17 

clinical_engagement 
diagnosis 
demography 
65 new agents 
75 
disease_progression 
H-positive risk:  855 776 116 1017 352 105 1019 353 141 53 150 63 
H-negative risk:  776 855 1019 1017 353 352 105 116 150 141 63 53 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 75 17 

clinical_engagement 
diagnosis 
demography 
70 new agents 
76 
disease_progression 
H-positive risk:  850 781 115 1017 351 106 1017 361 141 51 147 63 
H-negative risk:  781 850 1017 1017 361 351 106 115 147 141 63 51 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 75 17 

clinical_engagement 
diagnosis 
demography 
75 new agents 
77 
disease_progression 
H-positive risk:  851 787 114 1022 346 104 1011 359 143 49 149 65 
H-negative risk:  787 851 1011 1022 359 346 104 114 149 143 65 49 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 77 17 

clinical_engagement 
diagnosis 
demography 
77 new agents 
78 
disease_progression 
H-positive risk:  851 792 114 1022 351 105 1005 357 146 46 145 66 
H-negative risk:  792 851 1005 1022 357 351 105 114 145 146 66 46 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 77 17 

clinical_engagement 
diagnosis 
demography 
72 new agents 
79 
disease_progression 
H-positive risk:  857 791 112 1025 360 107 993 354 144 46 147 64 
H-negative risk:  791 857 993 1025 354 360 107 112 147 144 64 46 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 81 17 

clinical_engagement 
diagnosis 
demography 
78 new agents 
80 
disease_progression 
H-positive risk:  860 792 112 1018 362 107 998 345 146 47 151 62 
H-negative risk:  792 860 998 1018 345 362 107 112 151 146 62 47 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 78 17 

clinical_engagement 
diagnosis 
demography 
66 new agents 
81 
disease_progression 
H-positive risk:  863 791 113 1017 364 107 998 338 148 50 147 64 
H-negative risk:  791 863 998 1017 338 364 107 113 147 148 64 50 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 77 18 

clinical_engagement 
diagnosis 
demography 
69 new agents 
82 
disease_progression 
H-positive risk:  861 795 112 1018 358 106 1004 337 150 49 149 61 
H-negative risk:  795 861 1004 1018 337 358 106 112 149 150 61 49 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 77 18 

clinical_engagement 
diagnosis 
demography 
59 new agents 
83 
disease_progression 
H-positive risk:  864 794 113 1020 353 106 1003 341 150 49 147 60 
H-negative risk:  794 864 1003 1020 341 353 106 113 147 150 60 49 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 74 19 

clinical_engagement 
diagnosis 
demography 
75 new agents 
84 
disease_progression 
H-positive risk:  862 800 113 1026 353 107 995 341 147 48 148 60 
H-negative risk:  800 862 995 1026 341 353 107 113 148 147 60 48 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 75 17 

clinical_engagement 
diagnosis 
demography 
59 new agents 
85 
disease_progression 
H-positive risk:  803 730 112 1088 357 100 1059 338 153 48 153 59 
H-negative risk:  730 803 1059 1088 338 357 100 112 153 153 59 48 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 77 17 

clinical_engagement 
diagnosis 
demography 
93 new agents 
86 
disease_progression 
H-positive risk:  807 741 112 1061 377 100 1042 349 147 55 151 58 
H-negative risk:  741 807 1042 1061 349 377 100 112 151 147 58 55 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 76 17 

clinical_engagement 
diagnosis 
demography 
68 new agents 
87 
disease_progression 
H-positive risk:  808 742 110 1055 377 99 1044 352 151 54 150 58 
H-negative risk:  742 808 1044 1055 352 377 99 110 150 151 58 54 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 74 18 

clinical_engagement 
diagnosis 
demography 
64 new agents 
88 
disease_progression 
H-positive risk:  810 740 108 1058 377 101 1041 350 153 53 150 59 
H-negative risk:  740 810 1041 1058 350 377 101 108 150 153 59 53 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 74 19 

clinical_engagement 
diagnosis 
demography 
79 new agents 
89 
disease_progression 
H-positive risk:  819 736 109 1058 372 103 1040 350 150 53 152 58 
H-negative risk:  736 819 1040 1058 350 372 103 109 152 150 58 53 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 78 19 

clinical_engagement 
diagnosis 
demography 
68 new agents 
90 
disease_progression 
H-positive risk:  824 734 106 1058 376 100 1045 344 153 54 149 57 
H-negative risk:  734 824 1045 1058 344 376 100 106 149 153 57 54 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 80 19 

clinical_engagement 
diagnosis 
demography 
65 new agents 
91 
disease_progression 
H-positive risk:  824 732 107 1053 374 103 1053 345 152 54 147 56 
H-negative risk:  732 824 1053 1053 345 374 103 107 147 152 56 54 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 82 18 

clinical_engagement 
diagnosis 
demography 
71 new agents 
92 
disease_progression 
H-positive risk:  819 733 107 1053 374 101 1052 349 154 56 145 57 
H-negative risk:  733 819 1052 1053 349 374 101 107 145 154 57 56 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 81 19 

clinical_engagement 
diagnosis 
demography 
81 new agents 
93 
disease_progression 
H-positive risk:  817 745 109 1053 372 101 1053 339 157 55 143 56 
H-negative risk:  745 817 1053 1053 339 372 101 109 143 157 56 55 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 81 20 

clinical_engagement 
diagnosis 
demography 
104 new agents 
94 
disease_progression 
H-positive risk:  819 751 114 1052 363 101 1045 344 160 56 144 51 
H-negative risk:  751 819 1045 1052 344 363 101 114 144 160 51 56 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 84 21 

clinical_engagement 
diagnosis 
demography 
77 new agents 
95 
disease_progression 
H-positive risk:  823 749 115 1056 357 103 1039 347 160 57 144 50 
H-negative risk:  749 823 1039 1056 347 357 103 115 144 160 50 57 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 81 22 

clinical_engagement 
diagnosis 
demography 
64 new agents 
96 
disease_progression 
H-positive risk:  818 754 113 1058 350 100 1041 348 160 61 145 52 
H-negative risk:  754 818 1041 1058 348 350 100 113 145 160 52 61 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 82 20 

clinical_engagement 
diagnosis 
demography 
64 new agents 
97 
disease_progression 
H-positive risk:  769 712 100 1102 349 90 1094 342 169 59 159 55 
H-negative risk:  712 769 1094 1102 342 349 90 100 159 169 55 59 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 80 20 

clinical_engagement 
diagnosis 
demography 
121 new agents 
98 
disease_progression 
H-positive risk:  767 707 102 1087 357 92 1098 354 163 58 157 58 
H-negative risk:  707 767 1098 1087 354 357 92 102 157 163 58 58 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 82 19 

clinical_engagement 
diagnosis 
demography 
83 new agents 
99 
disease_progression 
H-positive risk:  771 708 105 1076 356 98 1089 361 162 60 155 59 
H-negative risk:  708 771 1089 1076 361 356 98 105 155 162 59 60 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 84 18 

clinical_engagement 
diagnosis 
demography 
70 new agents 
100 
disease_progression 
H-positive risk:  773 709 104 1068 361 97 1083 370 160 62 155 58 
H-negative risk:  709 773 1083 1068 370 361 97 104 155 160 58 62 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 87 18 

clinical_engagement 
diagnosis 
demography 
76 new agents 
101 
disease_progression 
H-positive risk:  781 708 101 1073 351 98 1088 363 158 61 159 59 
H-negative risk:  708 781 1088 1073 363 351 98 101 159 158 59 61 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 87 19 

clinical_engagement 
diagnosis 
demography 
88 new agents 
102 
disease_progression 
H-positive risk:  784 703 102 1081 351 98 1087 359 160 59 157 59 
H-negative risk:  703 784 1087 1081 359 351 98 102 157 160 59 59 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 90 19 

clinical_engagement 
diagnosis 
demography 
70 new agents 
103 
disease_progression 
H-positive risk:  777 707 101 1080 351 98 1089 359 162 57 158 61 
H-negative risk:  707 777 1089 1080 359 351 98 101 158 162 61 57 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 91 19 

clinical_engagement 
diagnosis 
demography 
71 new agents 
104 
disease_progression 
H-positive risk:  769 706 101 1086 350 98 1094 360 161 56 156 63 
H-negative risk:  706 769 1094 1086 360 350 98 101 156 161 63 56 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 90 18 

clinical_engagement 
diagnosis 
demography 
71 new agents 
105 
disease_progression 
H-positive risk:  766 704 101 1083 354 101 1097 362 159 57 155 61 
H-negative risk:  704 766 1097 1083 362 354 101 101 155 159 61 57 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 93 18 

clinical_engagement 
diagnosis 
demography 
73 new agents 
106 
disease_progression 
H-positive risk:  765 699 100 1094 357 105 1090 356 157 59 158 60 
H-negative risk:  699 765 1090 1094 356 357 105 100 158 157 60 59 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 92 20 

clinical_engagement 
diagnosis 
demography 
76 new agents 
107 
disease_progression 
H-positive risk:  767 702 101 1101 350 110 1081 354 152 63 161 58 
H-negative risk:  702 767 1081 1101 354 350 110 101 161 152 58 63 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 93 19 

clinical_engagement 
diagnosis 
demography 
72 new agents 
108 
disease_progression 
H-positive risk:  769 710 100 1103 349 109 1073 350 151 62 165 59 
H-negative risk:  710 769 1073 1103 350 349 109 100 165 151 59 62 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 92 20 

clinical_engagement 
diagnosis 
demography 
69 new agents 
109 
disease_progression 
H-positive risk:  720 675 95 1135 347 105 1122 349 159 64 169 60 
H-negative risk:  675 720 1122 1135 349 347 105 95 169 159 60 64 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 89 19 

clinical_engagement 
diagnosis 
demography 
89 new agents 
110 
disease_progression 
H-positive risk:  719 676 93 1126 353 105 1115 362 156 64 170 61 
H-negative risk:  676 719 1115 1126 362 353 105 93 170 156 61 64 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 92 20 

clinical_engagement 
diagnosis 
demography 
72 new agents 
111 
disease_progression 
H-positive risk:  715 680 94 1117 356 105 1113 368 156 67 169 60 
H-negative risk:  680 715 1113 1117 368 356 105 94 169 156 60 67 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 94 19 

clinical_engagement 
diagnosis 
demography 
69 new agents 
112 
disease_progression 
H-positive risk:  714 683 93 1112 351 105 1111 376 160 66 171 58 
H-negative risk:  683 714 1111 1112 376 351 105 93 171 160 58 66 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 95 19 

clinical_engagement 
diagnosis 
demography 
80 new agents 
113 
disease_progression 
H-positive risk:  709 686 93 1109 360 107 1108 374 159 67 172 56 
H-negative risk:  686 709 1108 1109 374 360 107 93 172 159 56 67 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 97 17 

clinical_engagement 
diagnosis 
demography 
72 new agents 
114 
disease_progression 
H-positive risk:  710 679 93 1112 364 104 1107 377 160 67 172 55 
H-negative risk:  679 710 1107 1112 377 364 104 93 172 160 55 67 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 96 17 

clinical_engagement 
diagnosis 
demography 
72 new agents 
115 
disease_progression 
H-positive risk:  711 684 93 1110 368 106 1107 376 159 65 169 52 
H-negative risk:  684 711 1107 1110 376 368 106 93 169 159 52 65 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 92 18 

clinical_engagement 
diagnosis 
demography 
71 new agents 
116 
disease_progression 
H-positive risk:  708 672 94 1126 368 106 1106 374 158 63 171 54 
H-negative risk:  672 708 1106 1126 374 368 106 94 171 158 54 63 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 96 18 

clinical_engagement 
diagnosis 
demography 
76 new agents 
117 
disease_progression 
H-positive risk:  707 678 94 1122 375 106 1102 372 155 63 172 54 
H-negative risk:  678 707 1102 1122 372 375 106 94 172 155 54 63 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 97 18 

clinical_engagement 
diagnosis 
demography 
48 new agents 
118 
disease_progression 
H-positive risk:  714 672 92 1123 376 105 1099 375 151 65 174 54 
H-negative risk:  672 714 1099 1123 375 376 105 92 174 151 54 65 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 97 19 

clinical_engagement 
diagnosis 
demography 
80 new agents 
119 
disease_progression 
H-positive risk:  710 680 93 1129 369 105 1101 374 151 63 171 54 
H-negative risk:  680 710 1101 1129 374 369 105 93 171 151 54 63 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 97 21 

clinical_engagement 
diagnosis 
demography 
66 new agents 
120 
disease_progression 
H-positive risk:  710 676 95 1133 368 106 1101 373 152 62 169 55 
H-negative risk:  676 710 1101 1133 373 368 106 95 169 152 55 62 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 96 20 

clinical_engagement 
diagnosis 
demography 
78 new agents 
121 
disease_progression 
H-positive risk:  662 641 92 1172 367 99 1144 370 157 63 177 56 
H-negative risk:  641 662 1144 1172 370 367 99 92 177 157 56 63 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 96 20 

clinical_engagement 
diagnosis 
demography 
78 new agents 
122 
disease_progression 
H-positive risk:  665 646 92 1146 387 97 1127 385 157 63 174 61 
H-negative risk:  646 665 1127 1146 385 387 97 92 174 157 61 63 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 98 20 

clinical_engagement 
diagnosis 
demography 
72 new agents 
123 
disease_progression 
H-positive risk:  660 646 91 1141 388 96 1139 384 161 60 174 60 
H-negative risk:  646 660 1139 1141 384 388 96 91 174 161 60 60 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 98 22 

clinical_engagement 
diagnosis 
demography 
65 new agents 
124 
disease_progression 
H-positive risk:  657 649 92 1144 375 98 1143 385 161 61 175 60 
H-negative risk:  649 657 1143 1144 385 375 98 92 175 161 60 61 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 100 23 

clinical_engagement 
diagnosis 
demography 
77 new agents 
125 
disease_progression 
H-positive risk:  656 644 93 1145 374 100 1144 390 159 61 175 59 
H-negative risk:  644 656 1144 1145 390 374 100 93 175 159 59 61 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 98 23 

clinical_engagement 
diagnosis 
demography 
65 new agents 
126 
disease_progression 
H-positive risk:  658 643 94 1141 374 96 1147 393 158 62 173 61 
H-negative risk:  643 658 1147 1141 393 374 96 94 173 158 61 62 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 97 23 

clinical_engagement 
diagnosis 
demography 
61 new agents 
127 
disease_progression 
H-positive risk:  657 642 96 1134 376 94 1153 395 157 63 173 60 
H-negative risk:  642 657 1153 1134 395 376 94 96 173 157 60 63 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 95 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
128 
disease_progression 
H-positive risk:  663 643 94 1141 372 94 1148 397 158 61 170 59 
H-negative risk:  643 663 1148 1141 397 372 94 94 170 158 59 61 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 92 26 

clinical_engagement 
diagnosis 
demography 
70 new agents 
129 
disease_progression 
H-positive risk:  661 644 92 1141 371 95 1152 397 154 62 169 62 
H-negative risk:  644 661 1152 1141 397 371 95 92 169 154 62 62 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 94 28 

clinical_engagement 
diagnosis 
demography 
71 new agents 
130 
disease_progression 
H-positive risk:  658 644 93 1129 379 94 1160 397 155 62 168 61 
H-negative risk:  644 658 1160 1129 397 379 94 93 168 155 61 62 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 94 28 

clinical_engagement 
diagnosis 
demography 
79 new agents 
131 
disease_progression 
H-positive risk:  655 644 93 1129 376 94 1165 400 153 62 168 61 
H-negative risk:  644 655 1165 1129 400 376 94 93 168 153 61 62 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 95 27 

clinical_engagement 
diagnosis 
demography 
74 new agents 
132 
disease_progression 
H-positive risk:  648 651 90 1138 377 95 1161 402 152 59 164 63 
H-negative risk:  651 648 1161 1138 402 377 95 90 164 152 63 59 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 95 26 

clinical_engagement 
diagnosis 
demography 
71 new agents 
133 
disease_progression 
H-positive risk:  653 654 90 1137 376 92 1159 403 149 55 170 62 
H-negative risk:  654 653 1159 1137 403 376 92 90 170 149 62 55 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 96 26 

clinical_engagement 
diagnosis 
demography 
115 new agents 
134 
disease_progression 
H-positive risk:  643 653 90 1134 381 95 1175 396 143 60 170 60 
H-negative risk:  653 643 1175 1134 396 381 95 90 170 143 60 60 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 95 26 

clinical_engagement 
diagnosis 
demography 
82 new agents 
135 
disease_progression 
H-positive risk:  638 659 89 1136 380 96 1172 393 144 61 171 61 
H-negative risk:  659 638 1172 1136 393 380 96 89 171 144 61 61 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 96 26 

clinical_engagement 
diagnosis 
demography 
92 new agents 
136 
disease_progression 
H-positive risk:  639 662 86 1137 383 98 1167 395 144 59 171 59 
H-negative risk:  662 639 1167 1137 395 383 98 86 171 144 59 59 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 92 26 

clinical_engagement 
diagnosis 
demography 
78 new agents 
137 
disease_progression 
H-positive risk:  633 658 88 1135 388 96 1167 394 147 61 173 60 
H-negative risk:  658 633 1167 1135 394 388 96 88 173 147 60 61 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 92 25 

clinical_engagement 
diagnosis 
demography 
88 new agents 
138 
disease_progression 
H-positive risk:  629 650 90 1145 387 98 1166 397 144 60 175 59 
H-negative risk:  650 629 1166 1145 397 387 98 90 175 144 59 60 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 88 27 

clinical_engagement 
diagnosis 
demography 
75 new agents 
139 
disease_progression 
H-positive risk:  629 651 95 1139 391 96 1158 405 140 59 177 60 
H-negative risk:  651 629 1158 1139 405 391 96 95 177 140 60 59 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 89 27 

clinical_engagement 
diagnosis 
demography 
79 new agents 
140 
disease_progression 
H-positive risk:  631 650 96 1138 381 94 1167 408 143 55 177 60 
H-negative risk:  650 631 1167 1138 408 381 94 96 177 143 60 55 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 85 28 

clinical_engagement 
diagnosis 
demography 
84 new agents 
141 
disease_progression 
H-positive risk:  626 653 96 1149 377 94 1170 406 140 55 176 58 
H-negative risk:  653 626 1170 1149 406 377 94 96 176 140 58 55 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 84 29 

clinical_engagement 
diagnosis 
demography 
73 new agents 
142 
disease_progression 
H-positive risk:  621 648 99 1157 378 96 1171 406 139 55 173 57 
H-negative risk:  648 621 1171 1157 406 378 96 99 173 139 57 55 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 87 30 

clinical_engagement 
diagnosis 
demography 
79 new agents 
143 
disease_progression 
H-positive risk:  620 644 94 1163 381 99 1178 403 137 52 169 60 
H-negative risk:  644 620 1178 1163 403 381 99 94 169 137 60 52 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 84 27 

clinical_engagement 
diagnosis 
demography 
71 new agents 
144 
disease_progression 
H-positive risk:  625 650 93 1164 379 98 1173 396 140 54 170 58 
H-negative risk:  650 625 1173 1164 396 379 98 93 170 140 58 54 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 83 28 

clinical_engagement 
diagnosis 
demography 
67 new agents 
145 
disease_progression 
H-positive risk:  619 643 92 1176 381 100 1175 394 142 52 169 57 
H-negative risk:  643 619 1175 1176 394 381 100 92 169 142 57 52 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 88 28 

clinical_engagement 
diagnosis 
demography 
80 new agents 
146 
disease_progression 
H-positive risk:  614 649 93 1162 383 98 1169 406 144 52 167 63 
H-negative risk:  649 614 1169 1162 406 383 98 93 167 144 63 52 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 89 28 

clinical_engagement 
diagnosis 
demography 
80 new agents 
147 
disease_progression 
H-positive risk:  610 642 96 1159 390 97 1179 398 146 53 168 62 
H-negative risk:  642 610 1179 1159 398 390 97 96 168 146 62 53 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 90 31 

clinical_engagement 
diagnosis 
demography 
60 new agents 
148 
disease_progression 
H-positive risk:  613 643 98 1163 386 101 1178 393 143 54 168 60 
H-negative risk:  643 613 1178 1163 393 386 101 98 168 143 60 54 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 95 31 

clinical_engagement 
diagnosis 
demography 
68 new agents 
149 
disease_progression 
H-positive risk:  624 643 98 1161 385 99 1175 393 145 51 164 62 
H-negative risk:  643 624 1175 1161 393 385 99 98 164 145 62 51 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 92 31 

clinical_engagement 
diagnosis 
demography 
65 new agents 
150 
disease_progression 
H-positive risk:  633 645 98 1166 378 101 1165 393 145 50 165 61 
H-negative risk:  645 633 1165 1166 393 378 101 98 165 145 61 50 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 90 29 

clinical_engagement 
diagnosis 
demography 
65 new agents 
151 
disease_progression 
H-positive risk:  633 646 96 1161 378 101 1162 400 144 48 170 61 
H-negative risk:  646 633 1162 1161 400 378 101 96 170 144 61 48 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 91 30 

clinical_engagement 
diagnosis 
demography 
73 new agents 
152 
disease_progression 
H-positive risk:  633 645 94 1164 380 101 1160 399 148 46 172 58 
H-negative risk:  645 633 1160 1164 399 380 101 94 172 148 58 46 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 86 30 

clinical_engagement 
diagnosis 
demography 
71 new agents 
153 
disease_progression 
H-positive risk:  634 650 94 1160 376 103 1159 397 152 46 170 59 
H-negative risk:  650 634 1159 1160 397 376 103 94 170 152 59 46 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 86 29 

clinical_engagement 
diagnosis 
demography 
84 new agents 
154 
disease_progression 
H-positive risk:  637 649 94 1160 372 103 1156 402 150 47 170 60 
H-negative risk:  649 637 1156 1160 402 372 103 94 170 150 60 47 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 89 28 

clinical_engagement 
diagnosis 
demography 
72 new agents 
155 
disease_progression 
H-positive risk:  643 653 91 1167 365 105 1153 399 149 45 171 59 
H-negative risk:  653 643 1153 1167 399 365 105 91 171 149 59 45 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 86 28 

clinical_engagement 
diagnosis 
demography 
76 new agents 
156 
disease_progression 
H-positive risk:  648 651 91 1161 373 105 1153 397 143 47 171 60 
H-negative risk:  651 648 1153 1161 397 373 105 91 171 143 60 47 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 89 26 

clinical_engagement 
diagnosis 
demography 
63 new agents 
157 
disease_progression 
H-positive risk:  645 649 90 1168 371 105 1152 395 152 45 169 59 
H-negative risk:  649 645 1152 1168 395 371 105 90 169 152 59 45 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 87 26 

clinical_engagement 
diagnosis 
demography 
79 new agents 
158 
disease_progression 
H-positive risk:  648 653 91 1157 376 103 1147 399 151 46 167 62 
H-negative risk:  653 648 1147 1157 399 376 103 91 167 151 62 46 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 87 25 

clinical_engagement 
diagnosis 
demography 
74 new agents 
159 
disease_progression 
H-positive risk:  650 645 90 1151 382 106 1144 401 156 46 166 63 
H-negative risk:  645 650 1144 1151 401 382 106 90 166 156 63 46 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 91 25 

clinical_engagement 
diagnosis 
demography 
78 new agents 
160 
disease_progression 
H-positive risk:  649 647 92 1143 382 106 1141 404 154 47 169 66 
H-negative risk:  647 649 1141 1143 404 382 106 92 169 154 66 47 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 89 22 

clinical_engagement 
diagnosis 
demography 
62 new agents 
161 
disease_progression 
H-positive risk:  642 649 93 1141 392 104 1143 402 154 47 172 61 
H-negative risk:  649 642 1143 1141 402 392 104 93 172 154 61 47 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 89 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
162 
disease_progression 
H-positive risk:  638 649 95 1154 387 102 1133 409 154 47 168 64 
H-negative risk:  649 638 1133 1154 409 387 102 95 168 154 64 47 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
65 new agents 
163 
disease_progression 
H-positive risk:  644 646 93 1152 389 103 1126 408 155 48 173 63 
H-negative risk:  646 644 1126 1152 408 389 103 93 173 155 63 48 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 87 24 

clinical_engagement 
diagnosis 
demography 
87 new agents 
164 
disease_progression 
H-positive risk:  650 644 93 1155 387 104 1129 401 151 52 171 63 
H-negative risk:  644 650 1129 1155 401 387 104 93 171 151 63 52 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
165 
disease_progression 
H-positive risk:  641 638 90 1162 390 103 1136 396 154 53 175 62 
H-negative risk:  638 641 1136 1162 396 390 103 90 175 154 62 53 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 87 21 

clinical_engagement 
diagnosis 
demography 
72 new agents 
166 
disease_progression 
H-positive risk:  639 638 86 1167 388 100 1142 392 157 55 175 61 
H-negative risk:  638 639 1142 1167 392 388 100 86 175 157 61 55 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
64 new agents 
167 
disease_progression 
H-positive risk:  641 643 86 1158 388 100 1138 398 155 55 177 61 
H-negative risk:  643 641 1138 1158 398 388 100 86 177 155 61 55 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 85 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
168 
disease_progression 
H-positive risk:  654 640 84 1157 385 103 1133 399 155 56 177 57 
H-negative risk:  640 654 1133 1157 399 385 103 84 177 155 57 56 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 82 23 

clinical_engagement 
diagnosis 
demography 
74 new agents 
169 
disease_progression 
H-positive risk:  663 640 82 1161 393 101 1127 391 155 53 175 59 
H-negative risk:  640 663 1127 1161 391 393 101 82 175 155 59 53 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
92 new agents 
170 
disease_progression 
H-positive risk:  663 645 81 1146 407 99 1131 389 156 53 168 62 
H-negative risk:  645 663 1131 1146 389 407 99 81 168 156 62 53 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 77 25 

clinical_engagement 
diagnosis 
demography 
64 new agents 
171 
disease_progression 
H-positive risk:  665 640 81 1142 403 98 1133 399 155 54 167 63 
H-negative risk:  640 665 1133 1142 399 403 98 81 167 155 63 54 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 80 26 

clinical_engagement 
diagnosis 
demography 
84 new agents 
172 
disease_progression 
H-positive risk:  677 634 81 1146 401 99 1130 401 152 57 160 62 
H-negative risk:  634 677 1130 1146 401 401 99 81 160 152 62 57 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
68 new agents 
173 
disease_progression 
H-positive risk:  674 625 82 1160 400 95 1140 390 156 60 158 60 
H-negative risk:  625 674 1140 1160 390 400 95 82 158 156 60 60 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
81 new agents 
174 
disease_progression 
H-positive risk:  668 628 80 1168 401 95 1146 383 157 60 152 62 
H-negative risk:  628 668 1146 1168 383 401 95 80 152 157 62 60 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 78 23 

clinical_engagement 
diagnosis 
demography 
68 new agents 
175 
disease_progression 
H-positive risk:  676 627 81 1160 405 94 1146 380 156 60 154 61 
H-negative risk:  627 676 1146 1160 380 405 94 81 154 156 61 60 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
176 
disease_progression 
H-positive risk:  678 632 81 1161 407 92 1139 375 158 61 156 60 
H-negative risk:  632 678 1139 1161 375 407 92 81 156 158 60 61 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 81 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
177 
disease_progression 
H-positive risk:  677 630 83 1169 404 90 1136 378 160 59 154 60 
H-negative risk:  630 677 1136 1169 378 404 90 83 154 160 60 59 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 77 25 

clinical_engagement 
diagnosis 
demography 
78 new agents 
178 
disease_progression 
H-positive risk:  674 634 83 1161 406 89 1150 369 159 62 155 58 
H-negative risk:  634 674 1150 1161 369 406 89 83 155 159 58 62 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
85 new agents 
179 
disease_progression 
H-positive risk:  678 638 83 1150 413 88 1156 364 157 61 157 55 
H-negative risk:  638 678 1156 1150 364 413 88 83 157 157 55 61 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
72 new agents 
180 
disease_progression 
H-positive risk:  669 639 84 1154 407 89 1162 364 157 61 160 54 
H-negative risk:  639 669 1162 1154 364 407 89 84 160 157 54 61 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
54 new agents 
181 
disease_progression 
H-positive risk:  664 633 86 1150 407 89 1175 363 156 62 159 56 
H-negative risk:  633 664 1175 1150 363 407 89 86 159 156 56 62 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 80 23 

clinical_engagement 
diagnosis 
demography 
94 new agents 
182 
disease_progression 
H-positive risk:  659 634 88 1145 413 92 1174 365 155 64 152 59 
H-negative risk:  634 659 1174 1145 365 413 92 88 152 155 59 64 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
79 new agents 
183 
disease_progression 
H-positive risk:  663 638 87 1141 404 91 1175 369 157 64 153 58 
H-negative risk:  638 663 1175 1141 369 404 91 87 153 157 58 64 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 79 21 

clinical_engagement 
diagnosis 
demography 
58 new agents 
184 
disease_progression 
H-positive risk:  658 638 89 1147 403 91 1170 377 155 62 152 58 
H-negative risk:  638 658 1170 1147 377 403 91 89 152 155 58 62 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 78 20 

clinical_engagement 
diagnosis 
demography 
60 new agents 
185 
disease_progression 
H-positive risk:  660 631 85 1141 400 94 1187 374 156 62 153 57 
H-negative risk:  631 660 1187 1141 374 400 94 85 153 156 57 62 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 80 21 

clinical_engagement 
diagnosis 
demography 
90 new agents 
186 
disease_progression 
H-positive risk:  660 640 85 1130 404 95 1187 377 154 59 151 58 
H-negative risk:  640 660 1187 1130 377 404 95 85 151 154 58 59 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 80 21 

clinical_engagement 
diagnosis 
demography 
92 new agents 
187 
disease_progression 
H-positive risk:  662 641 82 1134 404 92 1182 373 155 65 151 59 
H-negative risk:  641 662 1182 1134 373 404 92 82 151 155 59 65 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
188 
disease_progression 
H-positive risk:  672 638 80 1128 406 96 1181 369 155 65 152 58 
H-negative risk:  638 672 1181 1128 369 406 96 80 152 155 58 65 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 77 23 

clinical_engagement 
diagnosis 
demography 
76 new agents 
189 
disease_progression 
H-positive risk:  670 646 78 1125 402 96 1177 371 159 66 153 57 
H-negative risk:  646 670 1177 1125 371 402 96 78 153 159 57 66 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
190 
disease_progression 
H-positive risk:  675 642 77 1120 410 95 1171 378 158 64 154 56 
H-negative risk:  642 675 1171 1120 378 410 95 77 154 158 56 64 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
66 new agents 
191 
disease_progression 
H-positive risk:  670 642 78 1122 410 93 1177 372 159 64 154 59 
H-negative risk:  642 670 1177 1122 372 410 93 78 154 159 59 64 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
78 new agents 
192 
disease_progression 
H-positive risk:  664 646 77 1136 405 91 1173 374 159 64 154 57 
H-negative risk:  646 664 1173 1136 374 405 91 77 154 159 57 64 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 83 25 

clinical_engagement 
diagnosis 
demography 
89 new agents 
193 
disease_progression 
H-positive risk:  662 650 77 1126 419 89 1172 372 158 64 154 57 
H-negative risk:  650 662 1172 1126 372 419 89 77 154 158 57 64 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 82 26 

clinical_engagement 
diagnosis 
demography 
77 new agents 
194 
disease_progression 
H-positive risk:  667 648 79 1111 430 90 1169 379 157 63 148 59 
H-negative risk:  648 667 1169 1111 379 430 90 79 148 157 59 63 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 84 26 

clinical_engagement 
diagnosis 
demography 
73 new agents 
195 
disease_progression 
H-positive risk:  667 649 78 1108 433 89 1157 388 156 64 149 62 
H-negative risk:  649 667 1157 1108 388 433 89 78 149 156 62 64 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 83 25 

clinical_engagement 
diagnosis 
demography 
82 new agents 
196 
disease_progression 
H-positive risk:  663 657 77 1109 426 88 1157 386 157 67 154 59 
H-negative risk:  657 663 1157 1109 386 426 88 77 154 157 59 67 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 83 25 

clinical_engagement 
diagnosis 
demography 
74 new agents 
197 
disease_progression 
H-positive risk:  658 664 78 1112 421 89 1156 386 157 64 153 62 
H-negative risk:  664 658 1156 1112 386 421 89 78 153 157 62 64 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 81 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
198 
disease_progression 
H-positive risk:  657 669 78 1096 426 90 1152 389 159 67 154 63 
H-negative risk:  669 657 1152 1096 389 426 90 78 154 159 63 67 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
84 new agents 
199 
disease_progression 
H-positive risk:  657 673 78 1089 435 90 1157 383 160 64 151 63 
H-negative risk:  673 657 1157 1089 383 435 90 78 151 160 63 64 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 77 25 

clinical_engagement 
diagnosis 
demography 
87 new agents 
200 
disease_progression 
H-positive risk:  658 668 79 1087 445 89 1166 381 156 62 149 60 
H-negative risk:  668 658 1166 1087 381 445 89 79 149 156 60 62 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
81 new agents 
201 
disease_progression 
H-positive risk:  662 668 79 1091 441 90 1151 391 155 65 149 58 
H-negative risk:  668 662 1151 1091 391 441 90 79 149 155 58 65 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 78 28 

clinical_engagement 
diagnosis 
demography 
62 new agents 
202 
disease_progression 
H-positive risk:  663 667 78 1096 439 89 1146 391 157 66 150 58 
H-negative risk:  667 663 1146 1096 391 439 89 78 150 157 58 66 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 79 29 

clinical_engagement 
diagnosis 
demography 
80 new agents 
203 
disease_progression 
H-positive risk:  668 662 81 1096 441 86 1145 391 157 66 150 57 
H-negative risk:  662 668 1145 1096 391 441 86 81 150 157 57 66 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 81 28 

clinical_engagement 
diagnosis 
demography 
77 new agents 
204 
disease_progression 
H-positive risk:  666 658 82 1100 437 86 1158 385 157 65 147 59 
H-negative risk:  658 666 1158 1100 385 437 86 82 147 157 59 65 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 84 28 

clinical_engagement 
diagnosis 
demography 
63 new agents 
205 
disease_progression 
H-positive risk:  663 650 80 1099 442 85 1157 391 157 64 152 60 
H-negative risk:  650 663 1157 1099 391 442 85 80 152 157 60 64 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 88 30 

clinical_engagement 
diagnosis 
demography 
90 new agents 
206 
disease_progression 
H-positive risk:  666 658 82 1095 456 86 1137 392 152 66 149 61 
H-negative risk:  658 666 1137 1095 392 456 86 82 149 152 61 66 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 88 30 

clinical_engagement 
diagnosis 
demography 
76 new agents 
207 
disease_progression 
H-positive risk:  668 661 82 1077 460 86 1145 395 154 63 148 61 
H-negative risk:  661 668 1145 1077 395 460 86 82 148 154 61 63 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 85 31 

clinical_engagement 
diagnosis 
demography 
79 new agents 
208 
disease_progression 
H-positive risk:  670 666 81 1075 457 85 1150 390 157 64 143 62 
H-negative risk:  666 670 1150 1075 390 457 85 81 143 157 62 64 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 85 32 

clinical_engagement 
diagnosis 
demography 
75 new agents 
209 
disease_progression 
H-positive risk:  675 670 82 1068 463 86 1140 394 157 62 140 63 
H-negative risk:  670 675 1140 1068 394 463 86 82 140 157 63 62 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 88 31 

clinical_engagement 
diagnosis 
demography 
60 new agents 
210 
disease_progression 
H-positive risk:  679 664 80 1075 462 84 1137 397 161 61 137 63 
H-negative risk:  664 679 1137 1075 397 462 84 80 137 161 63 61 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 87 31 

clinical_engagement 
diagnosis 
demography 
90 new agents 
211 
disease_progression 
H-positive risk:  672 677 82 1071 465 85 1142 387 160 62 136 61 
H-negative risk:  677 672 1142 1071 387 465 85 82 136 160 61 62 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 85 31 

clinical_engagement 
diagnosis 
demography 
73 new agents 
212 
disease_progression 
H-positive risk:  663 685 83 1070 458 85 1154 384 160 62 136 60 
H-negative risk:  685 663 1154 1070 384 458 85 83 136 160 60 62 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 88 31 

clinical_engagement 
diagnosis 
demography 
72 new agents 
213 
disease_progression 
H-positive risk:  660 675 83 1086 451 82 1152 391 162 63 138 57 
H-negative risk:  675 660 1152 1086 391 451 82 83 138 162 57 63 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 88 29 

clinical_engagement 
diagnosis 
demography 
79 new agents 
214 
disease_progression 
H-positive risk:  657 667 81 1091 456 86 1155 386 160 62 139 60 
H-negative risk:  667 657 1155 1091 386 456 86 81 139 160 60 62 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 89 29 

clinical_engagement 
diagnosis 
demography 
75 new agents 
215 
disease_progression 
H-positive risk:  665 665 78 1083 455 84 1159 389 157 64 141 60 
H-negative risk:  665 665 1159 1083 389 455 84 78 141 157 60 64 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 88 30 

clinical_engagement 
diagnosis 
demography 
81 new agents 
216 
disease_progression 
H-positive risk:  655 670 79 1095 444 84 1161 394 155 62 141 60 
H-negative risk:  670 655 1161 1095 394 444 84 79 141 155 60 62 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 86 30 

clinical_engagement 
diagnosis 
demography 
78 new agents 
217 
disease_progression 
H-positive risk:  663 671 82 1093 448 84 1143 404 147 67 136 62 
H-negative risk:  671 663 1143 1093 404 448 84 82 136 147 62 67 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 86 30 

clinical_engagement 
diagnosis 
demography 
84 new agents 
218 
disease_progression 
H-positive risk:  661 673 83 1089 447 82 1153 402 150 62 138 60 
H-negative risk:  673 661 1153 1089 402 447 82 83 138 150 60 62 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 80 30 

clinical_engagement 
diagnosis 
demography 
89 new agents 
219 
disease_progression 
H-positive risk:  663 673 82 1093 448 81 1147 410 150 62 136 55 
H-negative risk:  673 663 1147 1093 410 448 81 82 136 150 55 62 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 80 30 

clinical_engagement 
diagnosis 
demography 
75 new agents 
220 
disease_progression 
H-positive risk:  665 671 85 1092 456 80 1149 397 153 62 136 54 
H-negative risk:  671 665 1149 1092 397 456 80 85 136 153 54 62 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 84 29 

clinical_engagement 
diagnosis 
demography 
69 new agents 
221 
disease_progression 
H-positive risk:  668 669 83 1100 454 79 1146 400 152 61 136 52 
H-negative risk:  669 668 1146 1100 400 454 79 83 136 152 52 61 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 82 28 

clinical_engagement 
diagnosis 
demography 
82 new agents 
222 
disease_progression 
H-positive risk:  668 663 84 1098 460 78 1148 398 149 64 133 57 
H-negative risk:  663 668 1148 1098 398 460 78 84 133 149 57 64 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 83 26 

clinical_engagement 
diagnosis 
demography 
67 new agents 
223 
disease_progression 
H-positive risk:  667 663 84 1104 461 79 1145 401 151 60 132 53 
H-negative risk:  663 667 1145 1104 401 461 79 84 132 151 53 60 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 85 25 

clinical_engagement 
diagnosis 
demography 
85 new agents 
224 
disease_progression 
H-positive risk:  668 664 84 1102 458 79 1143 402 152 59 135 54 
H-negative risk:  664 668 1143 1102 402 458 79 84 135 152 54 59 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
225 
disease_progression 
H-positive risk:  670 666 87 1098 462 77 1136 406 150 59 132 57 
H-negative risk:  666 670 1136 1098 406 462 77 87 132 150 57 59 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 83 25 

clinical_engagement 
diagnosis 
demography 
96 new agents 
226 
disease_progression 
H-positive risk:  685 671 87 1099 459 75 1124 402 154 56 129 59 
H-negative risk:  671 685 1124 1099 402 459 75 87 129 154 59 56 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
227 
disease_progression 
H-positive risk:  697 673 92 1089 462 76 1117 402 151 55 126 60 
H-negative risk:  673 697 1117 1089 402 462 76 92 126 151 60 55 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
228 
disease_progression 
H-positive risk:  696 667 93 1102 454 78 1116 407 148 55 127 57 
H-negative risk:  667 696 1116 1102 407 454 78 93 127 148 57 55 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
68 new agents 
229 
disease_progression 
H-positive risk:  702 662 92 1092 467 79 1094 417 151 56 129 59 
H-negative risk:  662 702 1094 1092 417 467 79 92 129 151 59 56 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 86 24 

clinical_engagement 
diagnosis 
demography 
85 new agents 
230 
disease_progression 
H-positive risk:  707 669 95 1087 463 78 1090 417 152 56 128 58 
H-negative risk:  669 707 1090 1087 417 463 78 95 128 152 58 56 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
86 new agents 
231 
disease_progression 
H-positive risk:  713 669 95 1076 454 81 1095 423 153 54 127 60 
H-negative risk:  669 713 1095 1076 423 454 81 95 127 153 60 54 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
81 new agents 
232 
disease_progression 
H-positive risk:  712 669 97 1074 455 79 1099 425 152 55 124 59 
H-negative risk:  669 712 1099 1074 425 455 79 97 124 152 59 55 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 82 21 

clinical_engagement 
diagnosis 
demography 
68 new agents 
233 
disease_progression 
H-positive risk:  712 664 98 1071 453 80 1111 420 153 55 125 58 
H-negative risk:  664 712 1111 1071 420 453 80 98 125 153 58 55 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
60 new agents 
234 
disease_progression 
H-positive risk:  706 664 97 1073 452 79 1117 426 149 54 126 57 
H-negative risk:  664 706 1117 1073 426 452 79 97 126 149 57 54 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
77 new agents 
235 
disease_progression 
H-positive risk:  708 667 94 1060 458 83 1123 424 149 51 131 52 
H-negative risk:  667 708 1123 1060 424 458 83 94 131 149 52 51 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 85 20 

clinical_engagement 
diagnosis 
demography 
76 new agents 
236 
disease_progression 
H-positive risk:  706 668 96 1069 452 82 1121 422 149 54 128 53 
H-negative risk:  668 706 1121 1069 422 452 82 96 128 149 53 54 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 85 20 

clinical_engagement 
diagnosis 
demography 
66 new agents 
237 
disease_progression 
H-positive risk:  704 671 92 1071 455 82 1125 422 149 52 126 51 
H-negative risk:  671 704 1125 1071 422 455 82 92 126 149 51 52 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 86 21 

clinical_engagement 
diagnosis 
demography 
82 new agents 
238 
disease_progression 
H-positive risk:  709 669 94 1075 447 84 1119 426 148 54 128 47 
H-negative risk:  669 709 1119 1075 426 447 84 94 128 148 47 54 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 85 21 

clinical_engagement 
diagnosis 
demography 
84 new agents 
239 
disease_progression 
H-positive risk:  712 674 92 1071 442 85 1124 418 148 52 133 49 
H-negative risk:  674 712 1124 1071 418 442 85 92 133 148 49 52 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
240 
disease_progression 
H-positive risk:  711 680 92 1077 440 87 1119 411 149 51 129 54 
H-negative risk:  680 711 1119 1077 411 440 87 92 129 149 54 51 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
83 new agents 
241 
disease_progression 
H-positive risk:  716 681 88 1064 453 87 1112 414 150 49 132 54 
H-negative risk:  681 716 1112 1064 414 453 87 88 132 150 54 49 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 87 24 

clinical_engagement 
diagnosis 
demography 
81 new agents 
242 
disease_progression 
H-positive risk:  722 680 90 1062 456 87 1101 417 147 50 131 57 
H-negative risk:  680 722 1101 1062 417 456 87 90 131 147 57 50 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 87 24 

clinical_engagement 
diagnosis 
demography 
64 new agents 
243 
disease_progression 
H-positive risk:  721 674 91 1078 449 88 1099 416 145 50 129 60 
H-negative risk:  674 721 1099 1078 416 449 88 91 129 145 60 50 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 87 24 

clinical_engagement 
diagnosis 
demography 
79 new agents 
244 
disease_progression 
H-positive risk:  729 662 93 1078 451 89 1089 417 145 51 135 61 
H-negative risk:  662 729 1089 1078 417 451 89 93 135 145 61 51 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 88 23 

clinical_engagement 
diagnosis 
demography 
87 new agents 
245 
disease_progression 
H-positive risk:  731 663 91 1069 452 89 1086 425 144 52 138 60 
H-negative risk:  663 731 1086 1069 425 452 89 91 138 144 60 52 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 84 26 

clinical_engagement 
diagnosis 
demography 
68 new agents 
246 
disease_progression 
H-positive risk:  732 667 93 1072 446 86 1081 424 146 54 138 61 
H-negative risk:  667 732 1081 1072 424 446 86 93 138 146 61 54 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 86 25 

clinical_engagement 
diagnosis 
demography 
71 new agents 
247 
disease_progression 
H-positive risk:  728 670 93 1074 443 86 1083 427 147 51 138 60 
H-negative risk:  670 728 1083 1074 427 443 86 93 138 147 60 51 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 89 25 

clinical_engagement 
diagnosis 
demography 
82 new agents 
248 
disease_progression 
H-positive risk:  722 671 94 1076 444 84 1082 433 146 50 138 60 
H-negative risk:  671 722 1082 1076 433 444 84 94 138 146 60 50 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 90 24 

clinical_engagement 
diagnosis 
demography 
68 new agents 
249 
disease_progression 
H-positive risk:  712 668 95 1078 451 83 1097 424 147 49 140 56 
H-negative risk:  668 712 1097 1078 424 451 83 95 140 147 56 49 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 89 23 

clinical_engagement 
diagnosis 
demography 
68 new agents 
250 
disease_progression 
H-positive risk:  709 666 100 1081 448 85 1094 428 143 53 136 57 
H-negative risk:  666 709 1094 1081 428 448 85 100 136 143 57 53 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 92 23 

clinical_engagement 
diagnosis 
demography 
76 new agents 
251 
disease_progression 
H-positive risk:  707 669 99 1078 451 87 1097 421 143 53 136 59 
H-negative risk:  669 707 1097 1078 421 451 87 99 136 143 59 53 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 87 24 

clinical_engagement 
diagnosis 
demography 
79 new agents 
252 
disease_progression 
H-positive risk:  706 666 101 1078 455 88 1088 428 144 53 134 59 
H-negative risk:  666 706 1088 1078 428 455 88 101 134 144 59 53 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
65 new agents 
253 
disease_progression 
H-positive risk:  696 669 100 1074 457 93 1098 426 144 52 132 59 
H-negative risk:  669 696 1098 1074 426 457 93 100 132 144 59 52 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 88 24 

clinical_engagement 
diagnosis 
demography 
102 new agents 
254 
disease_progression 
H-positive risk:  700 667 100 1076 446 94 1107 427 141 52 132 58 
H-negative risk:  667 700 1107 1076 427 446 94 100 132 141 58 52 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 88 23 

clinical_engagement 
diagnosis 
demography 
74 new agents 
255 
disease_progression 
H-positive risk:  704 676 103 1070 446 94 1099 426 141 53 130 58 
H-negative risk:  676 704 1099 1070 426 446 94 103 130 141 58 53 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 91 19 

clinical_engagement 
diagnosis 
demography 
74 new agents 
256 
disease_progression 
H-positive risk:  704 676 104 1079 446 91 1096 418 143 55 129 59 
H-negative risk:  676 704 1096 1079 418 446 91 104 129 143 59 55 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 93 19 

clinical_engagement 
diagnosis 
demography 
72 new agents 
257 
disease_progression 
H-positive risk:  697 682 104 1078 438 92 1103 419 144 55 131 57 
H-negative risk:  682 697 1103 1078 419 438 92 104 131 144 57 55 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 95 19 

clinical_engagement 
diagnosis 
demography 
83 new agents 
258 
disease_progression 
H-positive risk:  704 692 104 1083 427 91 1101 406 148 53 133 58 
H-negative risk:  692 704 1101 1083 406 427 91 104 133 148 58 53 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 93 17 

clinical_engagement 
diagnosis 
demography 
83 new agents 
259 
disease_progression 
H-positive risk:  702 698 106 1084 424 91 1099 409 151 51 129 56 
H-negative risk:  698 702 1099 1084 409 424 91 106 129 151 56 51 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 97 17 

clinical_engagement 
diagnosis 
demography 
82 new agents 
260 
disease_progression 
H-positive risk:  699 699 103 1077 420 89 1107 411 155 52 130 58 
H-negative risk:  699 699 1107 1077 411 420 89 103 130 155 58 52 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 95 18 

clinical_engagement 
diagnosis 
demography 
85 new agents 
261 
disease_progression 
H-positive risk:  691 703 101 1077 425 88 1115 407 152 53 132 56 
H-negative risk:  703 691 1115 1077 407 425 88 101 132 152 56 53 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 97 18 

clinical_engagement 
diagnosis 
demography 
88 new agents 
262 
disease_progression 
H-positive risk:  691 708 101 1081 422 89 1110 407 152 54 131 54 
H-negative risk:  708 691 1110 1081 407 422 89 101 131 152 54 54 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 96 18 

clinical_engagement 
diagnosis 
demography 
93 new agents 
263 
disease_progression 
H-positive risk:  690 704 102 1086 427 90 1105 408 151 53 128 56 
H-negative risk:  704 690 1105 1086 408 427 90 102 128 151 56 53 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 96 18 

clinical_engagement 
diagnosis 
demography 
58 new agents 
264 
disease_progression 
H-positive risk:  680 709 102 1077 436 93 1103 409 152 52 130 57 
H-negative risk:  709 680 1103 1077 409 436 93 102 130 152 57 52 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 95 17 

clinical_engagement 
diagnosis 
demography 
98 new agents 
265 
disease_progression 
H-positive risk:  680 723 103 1067 433 92 1105 406 150 53 134 54 
H-negative risk:  723 680 1105 1067 406 433 92 103 134 150 54 53 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 94 19 

clinical_engagement 
diagnosis 
demography 
81 new agents 
266 
disease_progression 
H-positive risk:  680 735 103 1072 425 91 1103 406 147 53 132 53 
H-negative risk:  735 680 1103 1072 406 425 91 103 132 147 53 53 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 95 19 

clinical_engagement 
diagnosis 
demography 
58 new agents 
267 
disease_progression 
H-positive risk:  678 736 101 1074 421 91 1102 411 145 56 133 52 
H-negative risk:  736 678 1102 1074 411 421 91 101 133 145 52 56 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 94 20 

clinical_engagement 
diagnosis 
demography 
69 new agents 
268 
disease_progression 
H-positive risk:  685 725 100 1084 420 90 1095 417 145 54 134 51 
H-negative risk:  725 685 1095 1084 417 420 90 100 134 145 51 54 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 91 21 

clinical_engagement 
diagnosis 
demography 
74 new agents 
269 
disease_progression 
H-positive risk:  685 723 100 1083 428 89 1089 413 148 55 134 53 
H-negative risk:  723 685 1089 1083 413 428 89 100 134 148 53 55 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 90 20 

clinical_engagement 
diagnosis 
demography 
70 new agents 
270 
disease_progression 
H-positive risk:  684 723 101 1080 421 88 1094 412 146 59 138 54 
H-negative risk:  723 684 1094 1080 412 421 88 101 138 146 54 59 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 95 21 

clinical_engagement 
diagnosis 
demography 
89 new agents 
271 
disease_progression 
H-positive risk:  692 716 101 1070 421 83 1102 414 149 59 139 54 
H-negative risk:  716 692 1102 1070 414 421 83 101 139 149 54 59 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 95 21 

clinical_engagement 
diagnosis 
demography 
92 new agents 
272 
disease_progression 
H-positive risk:  696 716 103 1074 418 85 1100 405 146 60 144 53 
H-negative risk:  716 696 1100 1074 405 418 85 103 144 146 53 60 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 90 20 

clinical_engagement 
diagnosis 
demography 
80 new agents 
273 
disease_progression 
H-positive risk:  695 711 101 1072 421 86 1112 398 146 60 149 49 
H-negative risk:  711 695 1112 1072 398 421 86 101 149 146 49 60 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 93 19 

clinical_engagement 
diagnosis 
demography 
72 new agents 
274 
disease_progression 
H-positive risk:  689 714 101 1072 420 87 1108 400 145 62 151 51 
H-negative risk:  714 689 1108 1072 400 420 87 101 151 145 51 62 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 92 18 

clinical_engagement 
diagnosis 
demography 
89 new agents 
275 
disease_progression 
H-positive risk:  680 712 102 1085 417 87 1116 399 145 57 148 52 
H-negative risk:  712 680 1116 1085 399 417 87 102 148 145 52 57 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 90 18 

clinical_engagement 
diagnosis 
demography 
69 new agents 
276 
disease_progression 
H-positive risk:  678 716 104 1084 414 88 1122 393 141 60 146 54 
H-negative risk:  716 678 1122 1084 393 414 88 104 146 141 54 60 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 91 17 

clinical_engagement 
diagnosis 
demography 
68 new agents 
277 
disease_progression 
H-positive risk:  685 709 101 1086 413 88 1125 390 142 59 146 56 
H-negative risk:  709 685 1125 1086 390 413 88 101 146 142 56 59 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 91 18 

clinical_engagement 
diagnosis 
demography 
74 new agents 
278 
disease_progression 
H-positive risk:  683 704 99 1098 402 87 1120 395 144 59 151 58 
H-negative risk:  704 683 1120 1098 395 402 87 99 151 144 58 59 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 91 18 

clinical_engagement 
diagnosis 
demography 
102 new agents 
279 
disease_progression 
H-positive risk:  689 711 100 1095 398 83 1114 395 145 57 155 58 
H-negative risk:  711 689 1114 1095 395 398 83 100 155 145 58 57 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 91 18 

clinical_engagement 
diagnosis 
demography 
77 new agents 
280 
disease_progression 
H-positive risk:  690 716 100 1090 403 82 1109 395 148 56 152 59 
H-negative risk:  716 690 1109 1090 395 403 82 100 152 148 59 56 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 90 17 

clinical_engagement 
diagnosis 
demography 
80 new agents 
281 
disease_progression 
H-positive risk:  696 719 100 1099 403 83 1095 396 146 56 147 60 
H-negative risk:  719 696 1095 1099 396 403 83 100 147 146 60 56 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 90 17 

clinical_engagement 
diagnosis 
demography 
75 new agents 
282 
disease_progression 
H-positive risk:  700 717 100 1098 410 83 1089 395 142 57 150 59 
H-negative risk:  717 700 1089 1098 395 410 83 100 150 142 59 57 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 87 18 

clinical_engagement 
diagnosis 
demography 
74 new agents 
283 
disease_progression 
H-positive risk:  702 722 99 1098 412 85 1087 385 144 58 149 59 
H-negative risk:  722 702 1087 1098 385 412 85 99 149 144 59 58 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 89 18 

clinical_engagement 
diagnosis 
demography 
59 new agents 
284 
disease_progression 
H-positive risk:  696 719 100 1098 413 84 1088 390 143 61 150 58 
H-negative risk:  719 696 1088 1098 390 413 84 100 150 143 58 61 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 95 19 

clinical_engagement 
diagnosis 
demography 
83 new agents 
285 
disease_progression 
H-positive risk:  694 720 99 1103 414 83 1080 388 150 62 148 59 
H-negative risk:  720 694 1080 1103 388 414 83 99 148 150 59 62 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 95 20 

clinical_engagement 
diagnosis 
demography 
86 new agents 
286 
disease_progression 
H-positive risk:  697 721 97 1096 418 81 1085 392 151 59 148 55 
H-negative risk:  721 697 1085 1096 392 418 81 97 148 151 55 59 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 98 20 

clinical_engagement 
diagnosis 
demography 
68 new agents 
287 
disease_progression 
H-positive risk:  702 715 97 1099 418 82 1087 390 150 58 147 55 
H-negative risk:  715 702 1087 1099 390 418 82 97 147 150 55 58 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 96 19 

clinical_engagement 
diagnosis 
demography 
96 new agents 
288 
disease_progression 
H-positive risk:  706 711 96 1096 425 84 1079 397 147 57 143 59 
H-negative risk:  711 706 1079 1096 397 425 84 96 143 147 59 57 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 98 19 

clinical_engagement 
diagnosis 
demography 
79 new agents 
289 
disease_progression 
H-positive risk:  699 717 94 1105 418 83 1079 402 147 55 140 61 
H-negative risk:  717 699 1079 1105 402 418 83 94 140 147 61 55 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 99 19 

clinical_engagement 
diagnosis 
demography 
108 new agents 
290 
disease_progression 
H-positive risk:  706 711 91 1115 414 82 1084 400 147 52 137 61 
H-negative risk:  711 706 1084 1115 400 414 82 91 137 147 61 52 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 95 18 

clinical_engagement 
diagnosis 
demography 
83 new agents 
291 
disease_progression 
H-positive risk:  713 720 91 1113 411 86 1082 397 141 53 135 58 
H-negative risk:  720 713 1082 1113 397 411 86 91 135 141 58 53 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 94 17 

clinical_engagement 
diagnosis 
demography 
80 new agents 
292 
disease_progression 
H-positive risk:  711 713 90 1107 412 86 1094 397 139 56 134 61 
H-negative risk:  713 711 1094 1107 397 412 86 90 134 139 61 56 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 96 17 

clinical_engagement 
diagnosis 
demography 
67 new agents 
293 
disease_progression 
H-positive risk:  714 708 88 1103 421 88 1093 396 141 54 132 62 
H-negative risk:  708 714 1093 1103 396 421 88 88 132 141 62 54 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 96 18 

clinical_engagement 
diagnosis 
demography 
69 new agents 
294 
disease_progression 
H-positive risk:  711 704 89 1101 425 91 1092 396 142 56 134 59 
H-negative risk:  704 711 1092 1101 396 425 91 89 134 142 59 56 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 95 19 

clinical_engagement 
diagnosis 
demography 
66 new agents 
295 
disease_progression 
H-positive risk:  714 695 92 1099 426 90 1087 405 144 55 133 60 
H-negative risk:  695 714 1087 1099 405 426 90 92 133 144 60 55 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 93 20 

clinical_engagement 
diagnosis 
demography 
75 new agents 
296 
disease_progression 
H-positive risk:  717 702 93 1094 423 93 1080 406 141 53 139 59 
H-negative risk:  702 717 1080 1094 406 423 93 93 139 141 59 53 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 96 21 

clinical_engagement 
diagnosis 
demography 
80 new agents 
297 
disease_progression 
H-positive risk:  717 700 95 1097 418 90 1084 409 139 55 138 58 
H-negative risk:  700 717 1084 1097 409 418 90 95 138 139 58 55 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 96 21 

clinical_engagement 
diagnosis 
demography 
76 new agents 
298 
disease_progression 
H-positive risk:  710 699 96 1096 415 88 1094 405 139 58 143 57 
H-negative risk:  699 710 1094 1096 405 415 88 96 143 139 57 58 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 97 21 

clinical_engagement 
diagnosis 
demography 
84 new agents 
299 
disease_progression 
H-positive risk:  715 694 98 1102 412 87 1092 408 138 54 144 56 
H-negative risk:  694 715 1092 1102 408 412 87 98 144 138 56 54 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 94 21 

clinical_engagement 
diagnosis 
demography 
65 new agents 
300 
disease_progression 
H-positive risk:  714 685 99 1105 405 90 1089 419 137 57 143 57 
H-negative risk:  685 714 1089 1105 419 405 90 99 143 137 57 57 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 97 21 

clinical_engagement 
diagnosis 
demography 
74 new agents 
301 
disease_progression 
H-positive risk:  718 691 99 1093 404 93 1089 418 135 59 144 57 
H-negative risk:  691 718 1089 1093 418 404 93 99 144 135 57 59 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 96 23 

clinical_engagement 
diagnosis 
demography 
80 new agents 
302 
disease_progression 
H-positive risk:  715 695 97 1094 398 93 1096 414 137 57 145 59 
H-negative risk:  695 715 1096 1094 414 398 93 97 145 137 59 57 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 97 21 

clinical_engagement 
diagnosis 
demography 
66 new agents 
303 
disease_progression 
H-positive risk:  719 687 92 1102 404 93 1090 418 135 57 147 56 
H-negative risk:  687 719 1090 1102 418 404 93 92 147 135 56 57 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 99 21 

clinical_engagement 
diagnosis 
demography 
76 new agents 
304 
disease_progression 
H-positive risk:  715 678 91 1110 411 94 1088 416 134 59 149 55 
H-negative risk:  678 715 1088 1110 416 411 94 91 149 134 55 59 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 100 25 

clinical_engagement 
diagnosis 
demography 
67 new agents 
305 
disease_progression 
H-positive risk:  709 675 92 1112 414 93 1086 420 135 59 149 56 
H-negative risk:  675 709 1086 1112 420 414 93 92 149 135 56 59 
New BC onsets:  130
BC status:  4870 130 
BC subtype:  4870 105 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
306 
disease_progression 
H-positive risk:  713 674 94 1112 415 95 1081 419 136 58 146 57 
H-negative risk:  674 713 1081 1112 419 415 95 94 146 136 57 58 
New BC onsets:  129
BC status:  4871 129 
BC subtype:  4871 104 25 

clinical_engagement 
diagnosis 
demography 
68 new agents 
307 
disease_progression 
H-positive risk:  714 674 96 1119 414 95 1081 412 135 57 146 57 
H-negative risk:  674 714 1081 1119 412 414 95 96 146 135 57 57 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 104 23 

clinical_engagement 
diagnosis 
demography 
83 new agents 
308 
disease_progression 
H-positive risk:  727 682 97 1113 409 97 1072 408 133 59 147 56 
H-negative risk:  682 727 1072 1113 408 409 97 97 147 133 56 59 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 104 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
309 
disease_progression 
H-positive risk:  730 685 96 1109 405 100 1071 405 136 56 149 58 
H-negative risk:  685 730 1071 1109 405 405 100 96 149 136 58 56 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 103 22 

clinical_engagement 
diagnosis 
demography 
74 new agents 
310 
disease_progression 
H-positive risk:  725 686 99 1107 410 97 1078 406 135 57 144 56 
H-negative risk:  686 725 1078 1107 406 410 97 99 144 135 56 57 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 102 22 

clinical_engagement 
diagnosis 
demography 
61 new agents 
311 
disease_progression 
H-positive risk:  724 687 101 1100 411 99 1071 414 133 64 144 52 
H-negative risk:  687 724 1071 1100 414 411 99 101 144 133 52 64 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 103 21 

clinical_engagement 
diagnosis 
demography 
73 new agents 
312 
disease_progression 
H-positive risk:  722 686 101 1095 413 96 1076 417 135 64 142 53 
H-negative risk:  686 722 1076 1095 417 413 96 101 142 135 53 64 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 106 20 

clinical_engagement 
diagnosis 
demography 
74 new agents 
313 
disease_progression 
H-positive risk:  713 687 99 1097 415 96 1088 410 135 63 145 52 
H-negative risk:  687 713 1088 1097 410 415 96 99 145 135 52 63 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 104 20 

clinical_engagement 
diagnosis 
demography 
68 new agents 
314 
disease_progression 
H-positive risk:  712 682 98 1098 414 95 1097 411 133 63 145 52 
H-negative risk:  682 712 1097 1098 411 414 95 98 145 133 52 63 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 99 21 

clinical_engagement 
diagnosis 
demography 
75 new agents 
315 
disease_progression 
H-positive risk:  706 679 96 1103 421 95 1098 413 131 65 143 50 
H-negative risk:  679 706 1098 1103 413 421 95 96 143 131 50 65 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 95 21 

clinical_engagement 
diagnosis 
demography 
58 new agents 
316 
disease_progression 
H-positive risk:  702 677 96 1101 419 98 1091 426 131 63 147 49 
H-negative risk:  677 702 1091 1101 426 419 98 96 147 131 49 63 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 95 20 

clinical_engagement 
diagnosis 
demography 
77 new agents 
317 
disease_progression 
H-positive risk:  709 681 97 1099 418 96 1083 427 128 62 150 50 
H-negative risk:  681 709 1083 1099 427 418 96 97 150 128 50 62 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 94 20 

clinical_engagement 
diagnosis 
demography 
79 new agents 
318 
disease_progression 
H-positive risk:  714 682 96 1093 423 97 1083 424 130 61 148 49 
H-negative risk:  682 714 1083 1093 424 423 97 96 148 130 49 61 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 96 19 

clinical_engagement 
diagnosis 
demography 
77 new agents 
319 
disease_progression 
H-positive risk:  712 688 92 1093 420 99 1088 425 127 58 147 51 
H-negative risk:  688 712 1088 1093 425 420 99 92 147 127 51 58 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 99 19 

clinical_engagement 
diagnosis 
demography 
65 new agents 
320 
disease_progression 
H-positive risk:  724 685 90 1093 424 98 1079 430 127 57 145 48 
H-negative risk:  685 724 1079 1093 430 424 98 90 145 127 48 57 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 96 18 

clinical_engagement 
diagnosis 
demography 
72 new agents 
321 
disease_progression 
H-positive risk:  721 682 89 1099 424 98 1086 419 127 60 144 51 
H-negative risk:  682 721 1086 1099 419 424 98 89 144 127 51 60 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 93 19 

clinical_engagement 
diagnosis 
demography 
87 new agents 
322 
disease_progression 
H-positive risk:  719 685 88 1103 421 101 1078 419 125 62 146 53 
H-negative risk:  685 719 1078 1103 419 421 101 88 146 125 53 62 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 93 19 

clinical_engagement 
diagnosis 
demography 
77 new agents 
323 
disease_progression 
H-positive risk:  717 681 86 1107 422 100 1089 411 128 61 145 53 
H-negative risk:  681 717 1089 1107 411 422 100 86 145 128 53 61 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 90 18 

clinical_engagement 
diagnosis 
demography 
79 new agents 
324 
disease_progression 
H-positive risk:  716 679 89 1107 423 100 1088 408 131 58 147 54 
H-negative risk:  679 716 1088 1107 408 423 100 89 147 131 54 58 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 91 18 

clinical_engagement 
diagnosis 
demography 
72 new agents 
325 
disease_progression 
H-positive risk:  723 685 89 1104 418 99 1085 404 129 59 148 57 
H-negative risk:  685 723 1085 1104 404 418 99 89 148 129 57 59 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 93 18 

clinical_engagement 
diagnosis 
demography 
73 new agents 
326 
disease_progression 
H-positive risk:  724 690 87 1100 416 98 1088 398 131 60 151 57 
H-negative risk:  690 724 1088 1100 398 416 98 87 151 131 57 60 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 97 18 

clinical_engagement 
diagnosis 
demography 
78 new agents 
327 
disease_progression 
H-positive risk:  721 681 88 1095 427 98 1094 392 134 60 156 54 
H-negative risk:  681 721 1094 1095 392 427 98 88 156 134 54 60 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 98 17 

clinical_engagement 
diagnosis 
demography 
71 new agents 
328 
disease_progression 
H-positive risk:  723 689 89 1077 430 100 1106 384 135 57 154 56 
H-negative risk:  689 723 1106 1077 384 430 100 89 154 135 56 57 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 102 17 

clinical_engagement 
diagnosis 
demography 
86 new agents 
329 
disease_progression 
H-positive risk:  727 688 96 1079 423 99 1110 375 137 57 154 55 
H-negative risk:  688 727 1110 1079 375 423 99 96 154 137 55 57 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 100 16 

clinical_engagement 
diagnosis 
demography 
76 new agents 
330 
disease_progression 
H-positive risk:  731 688 96 1075 423 99 1109 381 141 54 153 50 
H-negative risk:  688 731 1109 1075 381 423 99 96 153 141 50 54 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 100 16 

clinical_engagement 
diagnosis 
demography 
91 new agents 
331 
disease_progression 
H-positive risk:  734 691 95 1059 424 96 1110 387 142 58 153 51 
H-negative risk:  691 734 1110 1059 387 424 96 95 153 142 51 58 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 102 15 

clinical_engagement 
diagnosis 
demography 
79 new agents 
332 
disease_progression 
H-positive risk:  727 682 96 1058 431 95 1109 396 147 58 152 49 
H-negative risk:  682 727 1109 1058 396 431 95 96 152 147 49 58 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 105 16 

clinical_engagement 
diagnosis 
demography 
83 new agents 
333 
disease_progression 
H-positive risk:  723 685 97 1055 427 95 1116 396 145 59 155 47 
H-negative risk:  685 723 1116 1055 396 427 95 97 155 145 47 59 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 106 16 

clinical_engagement 
diagnosis 
demography 
73 new agents 
334 
disease_progression 
H-positive risk:  725 693 97 1059 427 95 1109 392 143 59 155 46 
H-negative risk:  693 725 1109 1059 392 427 95 97 155 143 46 59 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 104 15 

clinical_engagement 
diagnosis 
demography 
78 new agents 
335 
disease_progression 
H-positive risk:  725 694 97 1056 422 93 1108 399 144 60 157 45 
H-negative risk:  694 725 1108 1056 399 422 93 97 157 144 45 60 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 103 14 

clinical_engagement 
diagnosis 
demography 
68 new agents 
336 
disease_progression 
H-positive risk:  725 704 98 1042 426 93 1106 400 144 59 157 46 
H-negative risk:  704 725 1106 1042 400 426 93 98 157 144 46 59 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 101 14 

clinical_engagement 
diagnosis 
demography 
76 new agents 
337 
disease_progression 
H-positive risk:  725 708 98 1050 431 92 1089 401 144 59 158 45 
H-negative risk:  708 725 1089 1050 401 431 92 98 158 144 45 59 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 101 14 

clinical_engagement 
diagnosis 
demography 
72 new agents 
338 
disease_progression 
H-positive risk:  727 702 99 1063 429 94 1093 391 144 57 154 47 
H-negative risk:  702 727 1093 1063 391 429 94 99 154 144 47 57 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 97 14 

clinical_engagement 
diagnosis 
demography 
67 new agents 
339 
disease_progression 
H-positive risk:  726 696 98 1050 436 93 1092 404 147 55 154 49 
H-negative risk:  696 726 1092 1050 404 436 93 98 154 147 49 55 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 95 14 

clinical_engagement 
diagnosis 
demography 
85 new agents 
340 
disease_progression 
H-positive risk:  719 697 103 1047 432 93 1094 406 146 57 156 50 
H-negative risk:  697 719 1094 1047 406 432 93 103 156 146 50 57 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 94 15 

clinical_engagement 
diagnosis 
demography 
95 new agents 
341 
disease_progression 
H-positive risk:  721 703 103 1041 427 95 1097 406 144 56 159 48 
H-negative risk:  703 721 1097 1041 406 427 95 103 159 144 48 56 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 93 15 

clinical_engagement 
diagnosis 
demography 
71 new agents 
342 
disease_progression 
H-positive risk:  720 698 103 1051 425 95 1095 410 141 59 155 48 
H-negative risk:  698 720 1095 1051 410 425 95 103 155 141 48 59 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 92 17 

clinical_engagement 
diagnosis 
demography 
65 new agents 
343 
disease_progression 
H-positive risk:  715 697 105 1052 430 96 1097 403 142 61 153 49 
H-negative risk:  697 715 1097 1052 403 430 96 105 153 142 49 61 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 90 17 

clinical_engagement 
diagnosis 
demography 
78 new agents 
344 
disease_progression 
H-positive risk:  717 697 106 1059 426 98 1090 407 141 62 150 47 
H-negative risk:  697 717 1090 1059 407 426 98 106 150 141 47 62 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 89 18 

clinical_engagement 
diagnosis 
demography 
87 new agents 
345 
disease_progression 
H-positive risk:  720 698 105 1059 422 96 1088 410 141 62 151 48 
H-negative risk:  698 720 1088 1059 410 422 96 105 151 141 48 62 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 89 17 

clinical_engagement 
diagnosis 
demography 
74 new agents 
346 
disease_progression 
H-positive risk:  714 698 105 1069 421 97 1084 413 140 60 149 50 
H-negative risk:  698 714 1084 1069 413 421 97 105 149 140 50 60 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 90 17 

clinical_engagement 
diagnosis 
demography 
66 new agents 
347 
disease_progression 
H-positive risk:  710 690 107 1072 427 96 1093 406 138 61 149 51 
H-negative risk:  690 710 1093 1072 406 427 96 107 149 138 51 61 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 91 17 

clinical_engagement 
diagnosis 
demography 
78 new agents 
348 
disease_progression 
H-positive risk:  703 691 107 1083 418 95 1098 402 139 65 148 51 
H-negative risk:  691 703 1098 1083 402 418 95 107 148 139 51 65 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 93 17 

clinical_engagement 
diagnosis 
demography 
80 new agents 
349 
disease_progression 
H-positive risk:  699 685 107 1086 425 94 1102 401 137 67 146 51 
H-negative risk:  685 699 1102 1086 401 425 94 107 146 137 51 67 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 93 17 

clinical_engagement 
diagnosis 
demography 
64 new agents 
350 
disease_progression 
H-positive risk:  693 686 105 1085 436 93 1098 400 137 67 148 52 
H-negative risk:  686 693 1098 1085 400 436 93 105 148 137 52 67 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 95 16 

clinical_engagement 
diagnosis 
demography 
88 new agents 
351 
disease_progression 
H-positive risk:  687 687 106 1095 434 89 1098 405 138 68 144 49 
H-negative risk:  687 687 1098 1095 405 434 89 106 144 138 49 68 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 99 16 

clinical_engagement 
diagnosis 
demography 
66 new agents 
352 
disease_progression 
H-positive risk:  688 700 103 1084 441 87 1094 404 138 65 148 48 
H-negative risk:  700 688 1094 1084 404 441 87 103 148 138 48 65 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 98 16 

clinical_engagement 
diagnosis 
demography 
86 new agents 
353 
disease_progression 
H-positive risk:  685 700 103 1086 433 88 1092 413 136 63 150 51 
H-negative risk:  700 685 1092 1086 413 433 88 103 150 136 51 63 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 97 17 

clinical_engagement 
diagnosis 
demography 
81 new agents 
354 
disease_progression 
H-positive risk:  685 701 101 1080 439 88 1098 408 135 63 149 53 
H-negative risk:  701 685 1098 1080 408 439 88 101 149 135 53 63 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 97 17 

clinical_engagement 
diagnosis 
demography 
72 new agents 
355 
disease_progression 
H-positive risk:  682 703 100 1080 442 91 1093 410 134 62 150 53 
H-negative risk:  703 682 1093 1080 410 442 91 100 150 134 53 62 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 100 18 

clinical_engagement 
diagnosis 
demography 
65 new agents 
356 
disease_progression 
H-positive risk:  672 695 100 1074 449 91 1107 409 136 60 155 52 
H-negative risk:  695 672 1107 1074 409 449 91 100 155 136 52 60 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 101 17 

clinical_engagement 
diagnosis 
demography 
72 new agents 
357 
disease_progression 
H-positive risk:  668 696 101 1075 443 93 1111 404 135 64 156 54 
H-negative risk:  696 668 1111 1075 404 443 93 101 156 135 54 64 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 103 17 

clinical_engagement 
diagnosis 
demography 
74 new agents 
358 
disease_progression 
H-positive risk:  659 700 104 1080 440 94 1116 399 136 64 154 54 
H-negative risk:  700 659 1116 1080 399 440 94 104 154 136 54 64 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 103 19 

clinical_engagement 
diagnosis 
demography 
68 new agents 
359 
disease_progression 
H-positive risk:  652 704 103 1082 444 94 1118 392 136 65 154 56 
H-negative risk:  704 652 1118 1082 392 444 94 103 154 136 56 65 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 101 17 

clinical_engagement 
diagnosis 
demography 
81 new agents 
360 
disease_progression 
H-positive risk:  652 702 103 1085 447 94 1119 385 139 64 156 54 
H-negative risk:  702 652 1119 1085 385 447 94 103 156 139 54 64 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 101 14 

clinical_engagement 
diagnosis 
demography 
79 new agents 
Time difference of 18.75483 mins
This is task 25
date
